Tucker et al found that IL-2, IL-1b, and IL-6 were upregulated in cancer survivors exhibiting reduced sleep duration based on actigraph measurements, but not in patients with self-reported sleep disruption where instead IL-10 were found to be upregulated (Tucker et al., 2021). Here, IL1B is linked to cancer.